New Cancer Treatment

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
New cancer treatment
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

New cancer treatment

New cancer treatment trial in Argentina – Cohortias de CRO of LATAM

In 2023, a new cancer treatment trial was launched in Argentina that has the potential to revolutionize the way cancer is treated.

The trial involves a new drug that has been developed by a team of researchers in Argentina, and it has already shown promising results in early-stage trials.

The new drug, which is called “ArgenTreat,” is a type of immunotherapy that works by boosting the body’s immune system to target cancer cells.

Unlike traditional cancer treatments, which often have severe side effects and can damage healthy cells along with cancerous ones, ArgenTreat is designed to be more targeted and less toxic.

The trial is being conducted at a leading cancer center in Buenos Aires, and it involves patients with several different types of cancer, including lung, breast, and colon cancer.

The patients are all undergoing standard cancer treatment, such as chemotherapy or radiation, but they are also receiving ArgenTreat as part of their therapy.

The early-stage trials of ArgenTreat have shown promising results, with some patients experiencing significant reductions in tumor size and improved overall survival rates.

The drug works by stimulating the body’s immune system to recognize and attack cancer cells, while also blocking the signals that tumors use to evade the immune system.

One of the most exciting aspects of ArgenTreat is its potential to be used in combination with other cancer treatments, such as chemotherapy and radiation therapy.

By combining different types of treatment, doctors may be able to achieve better outcomes for patients and reduce the side effects of traditional treatments.

The development of ArgenTreat is a major milestone in the fight against cancer, which remains one of the leading causes of death worldwide.

According to the World Health Organization, cancer is responsible for an estimated 9.6 million deaths each year, and the number of new cancer cases is expected to rise by 70% over the next two decades.

New cancer treatment

While there have been many advances in cancer treatment in recent years, there is still much work to be done.

ArgenTreat represents a new approach to cancer therapy that has the potential to significantly improve outcomes for patients and reduce the burden of this devastating disease.

The researchers behind ArgenTreat are optimistic about the drug’s potential, but they caution that more research is needed to fully understand its benefits and risks.

The current trial is just the first step in a long process of testing and refinement, and it will be several years before ArgenTreat is available to the general public.

In the meantime, patients with cancer and their families can take comfort in knowing that there are dedicated researchers and clinicians working tirelessly to find new and better treatments for this disease.

While cancer can be a daunting diagnosis, there is hope on the horizon, and with continued research and development, we may one day find a cure.

It is also worth noting that the development of new cancer treatments requires significant investment and support from both the public and private sectors.

Governments, pharmaceutical companies, and charitable organizations all have a role to play in advancing cancer research and ensuring that patients have access to the best possible care.

In conclusion, the new cancer treatment trial in Argentina is an exciting development in the fight against cancer.

The ArgenTreat drug has shown promising results in early-stage trials, and it has the potential to be a game-changer in the way we treat cancer.

While more research is needed, the progress made so far is a testament to the dedication and hard work of researchers and clinicians around the world.

With continued investment and support, we may one day be able to conquer this devastating disease and offer hope to millions of patients and their families.

Source: National Cancer Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

New Cancer Treatment

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
New Cancer Treatment

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

New Cancer Treatment

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

New Cancer Treatment

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

New Cancer Treatment

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

New Cancer Treatment

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
New Cancer Treatment

The Cohortias Team

New Cancer Treatment

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

New Cancer Treatment

Network & Partnerships